DEF 14A Filing

Company

TG THERAPEUTICS, INC.

Filed

April 30, 2007

Period of Report

May 24, 2007

Accession Number

0001144204-07-021299

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →